ArticleLeukemia2016

Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients.

S Soverini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.